A new review of the evidence behind administering puberty blockers to children has said that the evidence available regarding “the clinical effectiveness, safety and cost-effectiveness” of administering puberty blockers to children, and adolescents aged 18 years or younger, is “of very low certainty.” All the studies considered by the review were deemed to “lack reasonable […]
